Pluristem Therapeutics Increases Testing of PLX Cells For Radiation (PSTI)

by Benzinga Staff
April 6, 2011 7:05 AM | 6 seconds read |
Pluristem Therapeutics PSTI increases its testing of PLX Cells for the treatment of radiation exposure.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDABiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved